Abstract:Based on the large celloidin‐embedded section method, human mandibles from 62 autopsied carcinoma cases were examined histologically to determine the pathological characteristics of any mandibular metaslases. Metastasis was confirmed histologically in 10 (16%) of the 62 cases and was comparatively frequent with gastric and pulmonary carcinomas. The hemopoietic areas in the mandibular marrow seemed to favor the early deposition of tumor cells. These micrometastatic foci seemed to increase in size, spreading to … Show more
“…Nevertheless, the incidence of metastatic tumors to the jaws is probably higher than suggested; micrometastatic foci in the jaws were found in 16 % of autopsied carcinoma cases despite the absence of radiologic findings [5]. Because of its rarity and the importance of early detection, the diagnosis is challenging and should be considered in the differential diagnosis of benign common oral inflammatory and reactive lesions [6][7][8][9][10].…”
Metastatic dissemination to the oral cavity is rare and is usually the evidence of a wide spread disease with an average survival rate of 7 months. In almost a quarter of the cases, oral metastasis was found to be the first indication of an occult malignancy at a distant site. Metastatic lesions can be found anywhere in the oral cavity, however, the jawbones with the molar area is the most frequently involved site. In the oral soft tissues, the gingiva is the most common site, suggesting the possible role of inflammation in the attraction of metastatic deposits. The most common primary malignancies presenting oral metastases were the lung, kidney, liver, and prostate for men, and breast, female genital organs, kidney, and colorectum for women. Most patients with jawbone metastasis complain of swelling, pain, and paresthesia. An exophytic lesion is the most common clinical presentation of metastatic lesions in the oral soft tissues. Early lesions, mainly those located in the gingiva, may resemble a hyperplastic or reactive lesion. Once a lesion is recognized as metastasis, the primary tumor site should be identified following clinical, radiological and histopathological investigations. If standardized diagnostic workup fails to detect the site of origin, then the term carcinoma of unknown primary is applied. Personalized medicine tools such as tissue-oforigin assays should be applied, either by immunohistochemical testing or by molecular-profiling methods as these may lead to a more favorable outcome.
“…Nevertheless, the incidence of metastatic tumors to the jaws is probably higher than suggested; micrometastatic foci in the jaws were found in 16 % of autopsied carcinoma cases despite the absence of radiologic findings [5]. Because of its rarity and the importance of early detection, the diagnosis is challenging and should be considered in the differential diagnosis of benign common oral inflammatory and reactive lesions [6][7][8][9][10].…”
Metastatic dissemination to the oral cavity is rare and is usually the evidence of a wide spread disease with an average survival rate of 7 months. In almost a quarter of the cases, oral metastasis was found to be the first indication of an occult malignancy at a distant site. Metastatic lesions can be found anywhere in the oral cavity, however, the jawbones with the molar area is the most frequently involved site. In the oral soft tissues, the gingiva is the most common site, suggesting the possible role of inflammation in the attraction of metastatic deposits. The most common primary malignancies presenting oral metastases were the lung, kidney, liver, and prostate for men, and breast, female genital organs, kidney, and colorectum for women. Most patients with jawbone metastasis complain of swelling, pain, and paresthesia. An exophytic lesion is the most common clinical presentation of metastatic lesions in the oral soft tissues. Early lesions, mainly those located in the gingiva, may resemble a hyperplastic or reactive lesion. Once a lesion is recognized as metastasis, the primary tumor site should be identified following clinical, radiological and histopathological investigations. If standardized diagnostic workup fails to detect the site of origin, then the term carcinoma of unknown primary is applied. Personalized medicine tools such as tissue-oforigin assays should be applied, either by immunohistochemical testing or by molecular-profiling methods as these may lead to a more favorable outcome.
“…La localisation de la tumeur primitive est une tache d'autant plus difficile que, d'une façon générale, toute tumeur à caractère métastatique peut coloniser la cavité buccale [13]. Les tumeurs primitives s'accompagnant le plus souvent des métastases mandibulaires sont celles du sein, du poumon, du rein, de la thyroïde, de la prostate, du testicule et de la vessie [5,7,13,16,17]. Le neuroblastome et les sarcomes (synovialosarcome, ostéosarcome et sarcome d'Ewing) retrouvés dans notre série sont rarement cités dans les séries publiées [11].…”
Section: Discussionunclassified
“…Selon Hashimoto et al [17], la fréquence des métastases varie selon le type histopathologique et le degré de différen-ciation de la tumeur primitive : la fréquence est plus élevée pour les carcinomes indifférenciés (29 %) et les adénocarci-nomes (20 %), que pour les aux carcinomes épidermoïdes.…”
“…This could be attributed to the high content of hematopoietic marrow in the mandible (10). Moreover, a reduced rate of blood flow in the angle of mandible may cause more frequent sedimentation of tumor emboli (11).…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.